It is also stated that subcutaneously injected sumatriptan should not be given to patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes, significant underlying cardiovascular diseases, ischemic cardiac syndromes such as angina pectoris of any type, all forms of myocardial infarction and silent myocardial ischemic.